See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Shanton Receives Fast Track Designation from US FDA for Refractory Gout Program

Summary by PR Newswire
/PRNewswire/ -- Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout, today announced that FDA has designated its...

23 Articles

Brunswicktimes GazetteBrunswicktimes Gazette
+22 Reposted by 22 other sources
Center

Shanton Receives Fast Track Designation from US FDA for Refractory Gout Program

SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout

·Lawrenceville, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 57% of the sources are Center
57% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States on Friday, July 25, 2025.
Sources are mostly out of (0)

Similar News Topics

Singapore, Singapore icon

Singapore, Singapore

News
For You
SearchBlindspotLocal